Skip to content

Asset turnover at other companies

Gilead Sciences logo
Gilead SciencesGILD
0.5×0.0×
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
0.5×+0.1×
Arrowhead Research logo
Arrowhead ResearchARWR
0.3×-0.1×
LQD
Liquidia CorporationLQDA
0.9×+0.8×
Alkermes logo
AlkermesALKS
0.5×-0.2×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.3×+0.1×

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s asset turnover?
Mirum Pharmaceuticals, Inc. (MIRM) reported asset turnover of 0.7× in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
Mirum Pharmaceuticals, Inc.'s asset turnover increased by 27.5% year-over-year, from 0.6× to 0.7×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.